DMD and Duchenne muscular dystrophy: Characterize the natural history of DMD disease progression using longitudinal data and modeling and simulation to support clinical trial design and interpretation of trial resultsUnderstand the effects of disease onset time/stage on disease progression, biomarker and efficacy endpointsIdentify more sensitive endpoints to predict DMD disease progression and long‐term efficacyComplement clinical trial data